1. Efficacy of continuous glucose monitoring in people living with diabetes and end stage kidney disease on dialysis: a systematic review
- Author
-
Yimeng Zhang, Pushpa Singh, Kavitha Ganapathy, Vijayan Suresh, Muhammad Ali Karamat, Jyoti Baharani, and Srikanth Bellary
- Subjects
Dialysis ,Diabetes mellitus ,Diabetic kidney disease ,Haemodialysis ,Peritoneal dialysis ,Systematic review ,Diseases of the genitourinary system. Urology ,RC870-923 - Abstract
Abstract Background Patients with diabetes on dialysis experience wide variations in glucose levels and an increased risk of hypoglycaemia. Due to the inaccuracies of HbA1c in dialysis patients, JBDS-IP and KDIGO recommend the use of continuous glucose monitoring (CGM). We conducted a systematic review to examine the current evidence for CGM use and its impact on clinical outcomes in patients with diabetes on dialysis. Methods A search of MEDLINE(R) ALL, Ovid Emcare, Journals@Ovid Full Text and Embase databases were conducted. Clinical or observational trials in adults with Type 1(T1D) or Type 2 (T2D) diabetes on dialysis and CGM intervention reporting on glycaemic outcomes were included. Results Of the 936 citations identified, 49 duplicates were removed. 887 citations were screened by title and abstract. 9 full texts were reviewed and a further 7 excluded due to duplications or failure to meet to selection criteria. Data was extracted for 2 studies, both prospective before-and-after interventional studies with no control group. Joubert et al. (2015) showed results for 15 participants with T1D. Mean CGM glucose level decreased from 8.37mmol/L at baseline to 7.7mmol/L at the end of the CGM period (p 10mmol/L decreased from 41 to 30% (p
- Published
- 2024
- Full Text
- View/download PDF